The Board of Management of LANXESS AG at the Annual Press Conference. From left to right: Dr. Rainier van Roessel, board member; CFO Matthias Zachert ; CEO Dr. Axel C. Heitmann, and board member Dr. Werner Breuers.

In his presentation, LANXESS CEO Dr. Axel C. Heitmann presented the Group’s results for 2010, which he said was the best year in the company’s history.

Management Board Chairman Dr. Axel C. Heitmann said LANXESS posted EBITDA pre exceptionals of EUR 918 million last year. This was almost double the 2009 figure and an improvement of 27 percent on 2008.

CEO Dr. Axel C. Heitmann during his presentation to the Annual Press Conference of LANXESS AG in Düsseldorf.

At the company’s Annual Press Conference, CEO Dr. Axel C. Heitmann emphasized that LANXESS is on a path of growth.

Matthias Zachert, Chief Financial Officer of LANXESS AG, addressing the Annual Press Conference. The CFO will leave LANXESS in April. His successor is Dr. Bernd Düttmann.

CFO Matthias Zachert addressing the Annual Press Conference of LANXESS AG in Düsseldorf.

Specialty chemicals group LANXESS presented its results for 2010 to an audience of international journalists in Düsseldorf.